New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease-Reference-Cited by-同舟云学术

New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease

Published:2014-04-28 Issue:9 Volume:57 Page:3773-3785
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

López-Iglesias Beatriz¹,Pérez Concepción¹,Morales-García José A.²³,Alonso-Gil Sandra²³,Pérez-Castillo Ana²³,Romero Alejandro⁴,López Manuela G.⁴,Villarroya Mercedes⁴,Conde Santiago¹,Rodríguez-Franco María Isabel¹

Affiliation:

1. Instituto de Química Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), C/Juan de la Cierva 3, 28006 Madrid, Spain

2. Instituto de Investigaciones Biomédicas “Alberto Sols”, Consejo Superior de Investigaciones Científicas (IIB-CSIC), C/Arturo Duperier 4, 28029 Madrid, Spain

3. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), C/ Valderrebollo 5, 28031 Madrid, Spain

4. Instituto Teófilo Hernando and Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029 Madrid, Spain

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm5000613

Reference60 articles.

1. The Public Health Impact of Alzheimer's Disease, 2000–2050: Potential Implication of Treatment Advances

2. Alzheimer's Disease

3. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.

4. Memantine in Patients with Moderate to Severe Alzheimer's Disease: Meta-Analyses Using Realistic Definitions of Response

5. Amyloid-cholinesterase interactions

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties;European Journal of Medicinal Chemistry;2024-11

2. Discovery of a Potent Melatonin-Based Inhibitor of Quinone Reductase-2 with Neuroprotective and Neurogenic Properties;2024

3. Phytochemical Studies, Anti-Oxidant and Anti- Inflammatory Properties of Four Medicinal Plants;Journal of Ecophysiology and Occupational Health;2023-12-15

4. Design and development of benzyl piperazine linked 5-phenyl-1,2,4-triazole-3-thione conjugates as potential agents to combat Alzheimer’s disease;Bioorganic Chemistry;2023-10

5. Tryptamine: A privileged scaffold for the management of Alzheimer's disease;Drug Development Research;2023-09-07